Pages that link to "Q74609409"

The following pages link to Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model (Q74609409):

Displaying 39 items.

• Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth (Q28478494) (← links)
• Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network. (Q31122538) (← links)
• Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo (Q33752520) (← links)
• Aerosol gemcitabine: preclinical safety and in vivo antitumor activity in osteosarcoma-bearing dogs (Q33926491) (← links)
• Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance (Q33934763) (← links)
• Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model (Q33987004) (← links)
• Inhalation Delivery of a Novel Diindolylmethane Derivative for the Treatment of Lung Cancer (Q34300257) (← links)
• Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis (Q34308740) (← links)
• Endogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases. (Q34534060) (← links)
• Ethanolic Extract of Marsdenia condurango Ameliorates Benzo[a]pyrene-induced Lung Cancer of Rats: Condurango Ameliorates BaP-induced Lung Cancer in Rats (Q35093681) (← links)
• Effect of the histone deacetylase inhibitor SNDX‐275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases (Q35106102) (← links)
• Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer (Q36302124) (← links)
• Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. (Q36489941) (← links)
• Improved biochemical strategies for targeted delivery of taxoids (Q36642502) (← links)
• Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics (Q36649540) (← links)
• Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention (Q37672440) (← links)
• Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery (Q37978509) (← links)
• Inhaled chemotherapy in lung cancer: future concept of nanomedicine (Q38012447) (← links)
• Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications (Q38759181) (← links)
• Nanomedicines for renal disease: current status and future applications (Q38802375) (← links)
• Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice (Q39175407) (← links)
• Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities (Q39306543) (← links)
• Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells (Q39496976) (← links)
• Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulization. (Q40046767) (← links)
• Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells (Q40419596) (← links)
• Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration (Q44471057) (← links)
• Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats. (Q47148526) (← links)
• Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo (Q49238970) (← links)
• Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide (Q50044586) (← links)
• Nebulization of Cyclic Arginine-Glycine-(D)-Aspartic Acid-Peptide Grafted and Drug Encapsulated Liposomes for Inhibition of Acute Lung Injury (Q51740496) (← links)
• Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. (Q53234775) (← links)
• Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles (Q57069731) (← links)
• Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac) in a Rodent Model (Q57787012) (← links)
• Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung (Q83309987) (← links)
• Paclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: Formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation (Q84111887) (← links)
• Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases (Q90647563) (← links)
• Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer (Q92199483) (← links)
• Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells (Q92905015) (← links)
• Inhaled chemotherapy adverse effects: mechanisms and protection methods (Q92953557) (← links)